Company: SXTPW
Filing Date: 2025-07-07
Form Type: S-1
Source: 0001213900-25-061842
Chunk: 48

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-07
Form: S-1
Chunk 48
---
-19 outbreaks; |

| ● | changes in our capital structure, such as future issuances of debt or equity securities; |

| ● | short sales, hedging and other derivative transactions involving our capital stock; and |

| ● | general economic and geopolitical conditions. |

In addition, if the market for stocks in our industry
or the stock market, in general, experiences a loss of investor confidence, the trading price of our common stock could decline for reasons
unrelated to our business, results of operations or financial condition. The trading price of our common stock might also decline in reaction
to events that affect other companies in our industry even if these events do not directly affect us. In the past, following periods of
volatility in the market price of a company’s securities, securities class action litigation has often been brought against that
company. If our stock price is volatile, we may become the target of securities litigation. Securities litigation could result in substantial
costs and divert our management’s attention and resources from our business. This could have a material adverse effect on our business,
results of operations, and financial condition.

We may not be able to maintain the listing of our common stock on Nasdaq, which could adversely affect our liquidity and the trading volume and market price of our common stock and decrease or eliminate your investment.

Our common stock is listed on The Nasdaq Capital
Market. If we violate the maintenance requirements for continued listing of our common stock, our common stock may be delisted. In the
past, we have received letters from Nasdaq notifying us that we were not in compliance with the $1.00 minimum bid price requirement for
continued listing on Nasdaq under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). Although we have complied with the
Bid Price Rule as of the date of this prospectus, there can be no assurance that we will maintain compliance with the Bid Price Rule or
any other applicable Listing Rules of Nasdaq. Nasdaq could issue us another letter notifying us of our non-compliance if our shares of
common stock trade less than $1.00 per share for 30 consecutive business days, and in that event, subsequently make a determination to
delist our common stock if we fail to take appropriate action.

Nasdaq requires us to have, among other requirements,
including the Bid Price Rule, a minimum amount of shareholders’ equity of $2.5 million in order to maintain our listing. Currently,
our as adjusted shareholders’ equity